Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

PLEKHA6 Activators

Plekha6 Activators represent a specialized class of chemical compounds that have garnered attention in the field of molecular biology and cellular research. These activators are designed to modulate the activity of the PLEKHA6 gene, where PLEKHA6 stands for Pleckstrin Homology Domain-Containing Family A Member 6. The PLEKHA6 gene codes for a protein that contains pleckstrin homology (PH) domains, which are known for their involvement in cell signaling and membrane interactions.

The mechanism of action of Plekha6 Activators typically involves their interaction with specific regulatory elements within the PLEKHA6 gene, such as promoter regions or enhancer sequences. These interactions facilitate the upregulation of gene transcription, resulting in heightened synthesis of the PLEKHA6 protein. While the exact biological functions of PLEKHA6 are still under investigation, researchers are actively exploring its potential roles in cellular processes, including intracellular signaling, membrane dynamics, or potential contributions to various cellular responses. As our understanding of PLEKHA6 activation continues to evolve, the development and refinement of Plekha6 Activators offer the prospect of advancing our comprehension of molecular biology, molecular mechanisms, and the broader implications of PLEKHA6 in cellular functionality, potentially revealing novel aspects of cell signaling and membrane interactions.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

Retinoic acid, through retinoic acid receptors, affects transcription of numerous genes and could potentially influence the expression of PLEKHA6.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Forskolin raises intracellular cAMP levels, which can activate CREB and modulate gene transcription, potentially inducing PLEKHA6 expression.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

TSA, another histone deacetylase inhibitor, can alter chromatin structure and increase the expression of various genes, potentially PLEKHA6.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine inhibits DNA methylation, potentially leading to the activation of silenced genes, which could include PLEKHA6.

β-Estradiol

50-28-2sc-204431
sc-204431A
500 mg
5 g
$62.00
$178.00
8
(1)

Beta-estradiol can modulate gene expression via estrogen receptors, which may hypothetically result in the upregulation of PLEKHA6.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Genistein, a tyrosine kinase inhibitor and phytoestrogen, could affect gene expression profiles, potentially influencing PLEKHA6.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$30.00
$46.00
$82.00
$218.00
19
(3)

Similar to butyrate, sodium butyrate is a HDAC inhibitor and could lead to increased transcription of genes such as PLEKHA6.

D,L-Sulforaphane

4478-93-7sc-207495A
sc-207495B
sc-207495C
sc-207495
sc-207495E
sc-207495D
5 mg
10 mg
25 mg
1 g
10 g
250 mg
$150.00
$286.00
$479.00
$1299.00
$8299.00
$915.00
22
(1)

Sulforaphane may affect gene expression by activating NRF2 and influencing antioxidant response element-mediated transcription, possibly affecting PLEKHA6.

Histone Lysine Methyltransferase Inhibitor Inhibitor

935693-62-2 free basesc-202651
5 mg
$148.00
4
(1)

BIX-01294 is a G9a histone methyltransferase inhibitor that could alter chromatin states and gene expression, possibly including PLEKHA6.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$128.00
$505.00
2
(1)

RG108 is a DNA methyltransferase inhibitor, which can lead to demethylation and activation of gene promoters, potentially affecting PLEKHA6.